FDA Inspection 1190837 — Anna Zubrzycka-Sienkiewicz, M.D., Ph.D.
The FDA completed an inspection of Anna Zubrzycka-Sienkiewicz, M.D., Ph.D. on October 21, 2022 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 21, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional Details
Clinical Investigator (CI)